Arch Biopartners Inc.

ACHFF · OTC
Analyze with AI
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Activities
Net Income$0-$3,327-$1,408-$1,170
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1,958$25$110
Change in WC$0$0$0$0
Other Non-Cash-$2,331$1,135$1,862-$1,921
Operating Cash Flow-$2,331-$234$479-$2,981
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$350$500-$775$1,775
Stock Issued$1,363$128$370$1,046
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$210-$69-$16-$46
Financing Cash Flow$1,503$559-$421$2,775
Forex Effect$0$0$0$0
Net Chg. in Cash-$828$325$58-$205
Supplemental Information
Beg. Cash$831$506$448$654
End Cash$3$831$506$448
Free Cash Flow-$2,331-$234$479-$2,981